Clinical Trial Update: Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of combining oral azacitidine with salvage chemotherapy in patients with relapsed or refractory diffuse large B-cell lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Oral azacitidine (azacitidine (oral formulation))

Snippet

Sponsor: Medical University of South Carolina | Conditions: Large B-Cell Diffuse Lymphoma | Phase 1 | Status: COMPLETED